A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre‐transplantation for Ph⁺ acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort stud

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/10.1002/ajh.27516

Keywords:

Abstract:

Source: